Abstract:Objective To explore the predictive value of CK20,CDX2,CK7 tissue expression levels for postoperative curative effect and prognosis of colorectal cancer. Methods The basic data of 60 patients with colorectal cancer were collected and analyzed retrospectively.All patients underwent radical resection of rectal cancer.Immunohistochemical SP method was used to detect the expression of CK20,CDX2 and CK7 in tumor tissues,and the patients were followed up for one year.By reexamining colonoscopy,the patients were divided into a good prognosis group(n=26)and a poor prognosis group(n=34)according to whether the tumor recurred or metastasized after operation.Univariate analysis and multivariate Logistic regression analysis were used to analyze the influencing factors of the prognosis of colorectal cancer patients. Results Compared with before operation,after operation,the positive expression rates of CK20 and CK7 in colorectal cancer(80.00%,83.33%)decreased,but the positive expression rate of CDX2(76.66%)increased(P<0.05).The Logistic regression model showed that the mass size(P=0.034,OR=1.411),CK20(P=0.024,OR=1.850),CDX2(P=0.013,OR=1.540),CK7(P=0.012,OR=1.540). Conclusion The expression levels of CK20,CDX2 and CK7 play an important role in the occurrence and development of colorectal cancer,and have certain clinical application value in evaluating the postoperative curative effect and prognosis of colorectal cancer.
李文利, 王静, 孙务霞. CK20、CDX2、CK7组织表达水平对结直肠癌术后疗效及预后的预测价值[J]. 哈尔滨医药, 2024, 44(1): 14-16.
Li Wenli, Wang Jing, Sun Wuxia. The Predictive Value of the Expression Levels of CK20,CDX2 and CK7 in Colorectal Cancer Postoperative Efficacy and Prognosis. journal1, 2024, 44(1): 14-16.
[1] 毛胜冬. CDX-2、CK在结直肠癌组织中的表达及其临床意义[J].药物生物技术,2019,26(1):37-40. [2] 司海,刘然,熊中原,等.细胞角蛋白的表达水平与结直肠癌临床病理学特征的相关性研究[J].首都医科大学学报,2022,43(1):127-131. [3] Meagher NS,Wang L,Rambau PF,,et al.A combination of the immunohistochemical markers CK7.A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases[J].Mod Pathol.2019 Dec;32(12):1834-1846. [4] 中华人民共和国国家卫生和计划生育委员会医政医管局,中华医学会肿瘤学分会.结直肠癌诊疗规范(2015年版)[J].肿瘤综合治疗电子杂志,2017,3(1):6-24. [5] 韩克松,张帆,李翠玲,等.腹腔镜结直肠癌根治术后血清趋化因子配体5、循环肿瘤细胞CK 20表达与肿瘤复发、转移的关系研究[J].中国中西医结合外科杂志,2021,27(3):472-476. [6] 孙妮娜,韩川,倪阵,等.SOX2/CDX2/HNF4α在结直肠癌中的研究进展[J].山西医科大学学报,2019,50(5):690-694. [7] 刘睿,杨垒,颜浩.CK20、Nm23与Ki67蛋白在结直肠癌组织中的表达及意义[J].中国现代普通外科进展,2020,23(10):797-800. [8] Abdel-Rahman O,Karachiwala H.Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer;a pooled analysis of five randomized trials[J].Int J Colorectal Dis.2019 Oct;34(10):1741-1747.